Orthopedics Today Hawaii

Orthopedics Today Hawaii

Issue: February 2014
January 22, 2014
1 min read

Orthobiologics have great promise for treatment of hip fractures

Issue: February 2014
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WAILEA, Hawaii — Orthobiologics offer a faster track in hip fracture healing and show great promise for the future, according to a presenter, here.

“The most exciting thing is that everything is about to change. It is going to be exciting,” Thomas A. “Toney” Russell, MD, said here at Orthopedics Today Hawaii 2014.

Orthobiologics that are currently being used as implant surface enhancements have interference with fracture healing, he said. Numerous published studies have shown that orthobiologics have the ability to deliver materials and the biodegradability of the osteoconductive matrix, Russell noted.


Thomas A. "Toney" Russell

Orthobiologics applications now involve implant surface enhancements, hydroxyapatite coatings, systemic medication delivery, parathyroid hormone, bisphosphonates and biomaterials. Present problems as well as the future options for orthobiologics may include the use of new calcium phosphate cements with increased porosity, proper insertion and positioning, as well as implant interface augmentation, he said. ─ by Kristine Houck, MA, ELS


Russell TA. Will orthobiologics help fixation in hip fractures. Presented at: Orthopedics Today Hawaii 2014; Jan. 19-23, 2014; Wailea, Hawaii.

Disclosure: Russell receives a salary from Innovision Inc.; royalties from Smith & Nephew; is a patent holder for Innovision Inc., Smith & Nephew and Zimmer; and has ownership interest in Etex and Innovision Inc.